Evolution of the Average Target: Moderna, Inc.

Evolution of the Average Target - Moderna, Inc.

Evolution of the Target Price: Moderna, Inc.

Evolution of the Target Price - Moderna, Inc.

Changes in Analyst Recommendations: Moderna, Inc.

341e60ead3c5dadeb0df.czxS3lptMPkFF6l6fXuf_7y74xE0geA8qBt1fEtlb40.PV5_sAoneq51evkXNAiqqO2MiWNnsdRJmXgmKgpXJO4WDhSpD1p5o3902g~633740effe27d01907b80a7d19088ef4
10-09 BofA Securities Adjusts Price Target on Moderna to $200 From $170, Maintains Neutral Rating MT
10-08 Evercore ISI Adjusts Price Target on Moderna to $80 From $50 MT
10-07 Morgan Stanley Adjusts Price Target on Moderna to $95 From $89 MT
10-02 And in the End, Europe Takes the Hit Zonebourse
09-30 Citigroup Downgrades Moderna to Sell From Neutral, Adjusts Price Target to $80 From $60 MT
09-11 Berenberg Boosts Price Target on Moderna to $100 From $45, Keeps Hold Rating MT
09-09 Moderna Set for 3 Near-Term INT Data Readouts, UBS Says MT
09-03 Evercore ISI Adjusts Moderna Price Target to $80 From $50, Maintains In Line Rating MT
09-03 Wall Street's Triple Squeeze Zonebourse
09-03 Rothschild & Co Redburn Downgrades Moderna to Sell From Neutral, Adjusts PT to $81 From $40 MT
09-03 Analyst recommendations: Copart, Moderna, Broadcom, DuPont de Nemours… Zonebourse
08-28 Argus Research Upgrades Moderna to Buy From Hold, $180 Price Target MT
08-26 U.S. research roundup- Intuit, MongoDB, Zscaler RE
08-26 Deutsche Bank Adjusts Moderna Price Target to $125 From $45, Maintains Hold Rating MT
08-25 Moderna Shares Rise After Wolfe Research Upgrade MT
08-25 Wolfe Upgrades Moderna to Peer Perform From Underperform MT
08-24 Barclays Adjusts Price Target on Moderna to $125 From $48 MT
08-24 Analyst recommendations: Kimberly-Clark, Palantir, Snap, Crowdstrike, Accenture… Zonebourse
08-21 JPMorgan Adjusts Price Target on Moderna to $77 From $40, Keeps Underweight Rating MT
08-21 Analyst recommendations: Equifax, Medpace Holdings, Applied Materials, PayPal, Moderna… Zonebourse
08-20 UBS Adjusts Moderna Price Target to $150 From $50, Maintains Neutral Rating MT
08-20 Jefferies Adjusts Price Target on Moderna to $150 From $60, Keeps Hold Rating MT
08-20 Piper Sandler Adjusts Price Target on Moderna to $167 From $77, Keeps Overweight Rating MT
08-20 Analyst recommendations: Datadog, Merck, Estee Lauder, Moderna, Target… Zonebourse
08-19 Piper Sandler Adjusts Price Target on Moderna to $167 From $77, Maintains Overweight Rating MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
-43.3%
+5.65%
+9.33%
-0.99%
-0.52%
+8.56%
-0.8%
+26.78%
-8.67%
+2.34%
Average -0.16%
Weighted average by Cap. +3.92%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
23
Last Close Price
218.01USD
Average target price
123.61USD
Spread / Average Target
-43.30%
High Price Target
200.00USD
Spread / Highest target
-8.26%
Low Price Target
45.00USD
Spread / Lowest Target
-79.36%

Analyst Consensus Detail

Analyst consensus - Moderna, Inc.

Consensus revision (last 18 months)

Consensus revision (last 18 months) - Moderna, Inc.
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
BBB
MarketScreener Ratings - Moderna, Inc.
  1. Stock Market
  2. Stocks
  3. MRNA Stock
  4. Consensus Moderna, Inc.